Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC23268	MIV 150	A high-affinity, allosteric HIV-1 and HIV-2 reverse transcriptase inhibitor (NNRTI) with EC50 of 1 nM.
DC21592	ML165	A high-affinity, selective platelet integrin αIIbβ3 receptor antagonist with IC50 of 96 nM.
DC22429	4-BBPB Featured	A highly potent agonist of σ1 receptor with Ki of 0.8 nM.
DC22523	3-Deazaneplanocin A hydrochloride	A highly potent and competitive S-adenosylhomocysteine hydrolase inhibitor with Ki of 0.05 nM, also inhibits histone methyltransferase EZH2.
DC23476	MRS-2500	A highly potent and selective antagonist of the platelet P2Y1 receptor with Ki of 0.78 nM.
DC23477	MRS-2500 tetraammonium	A highly potent and selective antagonist of the platelet P2Y1 receptor with Ki of 0.78 nM.
DC21604	SA-57	A highly potent and selective dual FAAH/MAGL inhibitor with IC50 of 1-3 nM against FAAH, inhibits mouse (IC50=410 nM) and human (IC50=1.4 uM) MAGL.
DC11765	GRK2-IN-115h hydrochloride	A highly potent and selective GRK2 inhibitor with IC50 of 18 nM.
DC25060	XDM-CBP	A highly potent and selective inhibitor of CBP/p300 bromodomain with Kd of 0.23/0.47 uM respectively, with high selectivity over all other BD families, including the BET family.
DC21649	Volixibat potassium	A highly potent and selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT) in development for the treatment of nonalcoholic steatohepatitis (NASH)..
DC21648	Volixibat	A highly potent and selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT) in development for the treatment of nonalcoholic steatohepatitis (NASH)..
DC9843	AKR1C3 Inhibitor 5f Featured	A highly potent and selective inhibitor of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3.
DC22436	JDTic	A highly potent and selective kappa Opioid receptor (KOR) antagonist with Ki of 0.3 nM.
DC22674	TCV-309	A highly potent and selective platelet activating factor (PAF) antagonist.
DC22560	TCV-309 chloride	A highly potent and selective platelet activating factor (PAF) antagonist.
DC11779	TNKS-IN-41	A highly potent and selective tankyrase inhibitor with pIC50 of 8.5 and 8.1 for TNKS1 and TNKS2, respectively.
DC24134	GCGR-IN-1	A highly potent glucagon receptor antagonist..
DC24083	4-IBP Featured	A highly potent sigma receptor agonist with Ki of 1.7 nM and 25.2 nM for σ1 and σ2, respectively.
DC21813	MT-7716	A highly potent, brain-penetrating ORL1 receptor (NOP receptor) agonist with Ki of 0.76 and 0.50 nM for rat and human ORL1 receptors, respectively.
DC21258	LY 2812223	A highly potent, functionally selective mGlu2 receptor agonist with EC50 of 13.6 nM in GTPγS functional binding assay.
DC23409	AZD 8683	A highly potent, long acting muscarinic receptor M3 antagonist with pIC50 of 9.8, inhibits M3 receptor in guinea pig trachea with pA2 of 9.4.
DC22822	Saxagliptin hydrate	A highly potent, long-acting, orally active DPP4 inhibitor with Ki of 0.6 nM.
DC11861	TAK-441	A highly potent, orally active hedgehog signaling (Hh) inhibitor with IC50 of 4.4 nM in Gli-luc reporter assays.
DC23848	YM-359445	A highly potent, orally active VEGFR-2 inhibitor with IC50 of 8.5 nM, without activity against PKA, PKCα, PDK-1 and JNK3 (IC50>1 uM).
DC24063	Cediranib maleate Featured	A highly potent, orally bioavailable, pan-VEGFR inibitor with IC50 of 1, 5, 3 nM for VEGFR1, 2, 3, respectively.
DC21588	RS 102221	A highly potent, selective 5-HT2C receptor antagonist with pKi of 8.4 and 8.5 for human and rat 5-HT2C, respectively.
DC21690	SR 144528	A highly potent, selective and orally active antagonist of CB2 receptor with Ki of 0.6 nM.
DC23424	RO 5256390 Featured	A highly potent, selective and orally bioavailable trace amine-associated receptor 1 (TRRA1) full agonist with EC50 of 18 nM, >500-fold selectivity over human adrenergic α2A receptor.
DC21582	RO 5263397	A highly potent, selective and orally bioavailable trace amine-associated receptor 1 (TRRA1) partial agonist with EC50 of 17 nM, >1,000-fold selectivity over human adrenergic α2A receptor.
DC20333	Cdc7 inhibitor 7c	A highly potent, selective and time-dependent Cdc7 kinase inhibitor with IC50 of 0.7 nM with slow dissociation property, with 200-fold and >14,000-fold selectivity over CDK2 and ROCK1, respectively.

<Prev1...51 52 53 54 55...1297 Next>

Inhibitors & Agonists

Customized Consultation X

Your information is safe with us. * Required Fields.